RecruitingPhase 4NCT04849455

Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection

Erector Spinae Plane Block Catheters: The Role in Acute Postoperative Pain After Hepatic Resection With Intrathecal Morphine


Sponsor

University of California, San Diego

Enrollment

70 participants

Start Date

May 24, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

To determine whether the addition of erector spinae plane (ESP) catheters to existing multimodal analgesic regimen with intrathecal morphine provides superior postoperative analgesia in patients undergoing hepatic resection compared with patients not receiving ESP catheters.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called 0.2% ropivacaine local anesthetic continuous erector spinae plane block, a drug called 0.2% ropivacaine local anesthetic superficially taped continuous erector spinae plane block, and others for people with acute pain, anesthesia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUG0.2% ropivacaine local anesthetic continuous erector spinae plane block

Treatment- continuous erector spinae block catheter followed by an infusion of ropivacaine 0.2% at 10ml automatic set bolus per 60 minute with 2ml/hr continuous infusion (12mls/hr total per catheter)

DRUG0.2% ropivacaine local anesthetic superficially taped continuous erector spinae plane block

Placebo- Superficially placed (taped to the surface) erector spinae block catheter with a ropivacaine 0.2% infusion at 0.1ml /hr

DRUGSpinal Morphine

200-300 mcg of spinal morphine


Locations(1)

University of California, San Diego

San Diego, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04849455


Related Trials